ACTR-42 - PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) With and Without Temozolomide in the Treatment of Adult Patients with Supratentorial Low-Grade Glioma [NCT NCT02023905]

Friday, November 22

7:30 PM - 9:30 PM

Location: Ballroom Lawn

Poster Presenting Author(s)

Annette Molinaro

Professor
University of California San Francisco
Eduardo Rodriguez Almaraz

Sr. CRC Supervisor
University of California San Francisco
CD

Ciara Downey

University of California, San Francisco
JP

Joanna Phillips

Department of Neurological Surgery, University of California, San Francisco
NO

Nancy Ann Oberheim-Bush

Assistant Professor
UCSF
Nicholas Butowski

Full Professor
University of California San Francisco
Susan Chang

Director, Division of Neuro-Oncology
UCSF
MB

Mitchel Berger

Chair, Deparment of Neurological Surgery
University of California, San Francisco
MP

Michael Prados

University of California, San Francisco
Daphne Haas-Kogan

Dana-Farber Cancer Center
Jennifer Clarke

University of California, San Francisco